List/Grid CRISPR Therapeutic

Sickled and other red blood cells Credit: UCL Medical School

CRISPR gene editing reveals new therapeutic approach for sickle cell disease

An international team of scientists led by researchers at St. Jude Children’s Research Hospital has found a way to use CRISPR gene editing to help fix sickle cell disease and beta-thalassemia ...
This image of the Cas9 complex depicts the Cas9 protein (in light 
blue), along with its guide RNA (yellow), and target DNA (red). 
Image courtesy of Bang Wong, from source material provided by 
Feng Zhang.

Broad Institute, Harvard, and MIT license CRISPR-Cas9 technology to Editas

The Broad Institute, Harvard University, the Massachusetts Institute of Technology and Editas Medicine have entered into a
© 2017 CRISPR tools and Resources. All rights reserved.